News

“Understanding the impact of axSpA on pregnancy outcomes is a vital component of improving management of women with axSpA at every stage of their lives,” investigators stated.

The investigators assessed and validated 3 rule-based algorithms for C difficile infection detection.

Authors of the study on PRP in knee osteoarthritis addressed the concerns shared by physicians in response to the method of their research.

Treat-to-target is a key strategy used in the treatment of many chronic conditions. Test your knowledge of its use in rheumatoid arthritis.

Higher BMI in overweight category at midlife was associated with a greater burden of overall and CVD morbidity, as well as higher health care costs in older adulthood.

Investigators found that a starch- and sucrose-reduced diet (SSRD) increased the intake of several micronutrients which correlated weakly with symptom improvement.

A summarization of the in-depth review, editorial and synopsis provided by multiple experts after revising the updates to the VA/DoD joint clinical practice guideline for substance use disorders.

The abundance of ribotype 027 was low, while the prevalence of RT001 declined from 12.3% to 3.7% during the three-year study period.

Experts observed a significant increase in monthly overdose deaths during Spring 2020, before a gradual decrease to 2019 rates.

Evidence-informed interventions were suggested to improve influenza vaccination rates in pregnant women in addition to local and national guidelines.

For patients treated with DOACs, the investigators suggest temporarily interrupting treatment rather than continued use.

In 2020 many clinics shifted to telehealth or reduced-contact practices which applied to medication abortions. Physicians relied solely on history-based screening instead of ultrasonography or pelvic exams during this time and investigators analyzed the data.

A user fee goal date of August 17, 2022 has been assigned to teplizumab.

Despite this, participant race and ethnicity were still underreported.

Alcohol use was additionally associated with worse fibrosis, but no interaction was noted between the two risk factors.

Overall tobacco use declined among adults since 2019—but many from varying sociodemographic backgrounds are still reporting high use.

Because Sjögren's Syndrome is often undetected or misdiagnosed, investigators developed the Sjögren's Syndrome Screening Questionnaire (SSSQ).

New data support the continued assessment of the investigative drug for adults with SLE.

Investigators were uncertain as to whether low fecal Alistipes could be used as a marker for predicting the outcome of FMT.

Investigators suggested that prediction tools such as the decision-making support tool PREDAFLU could be used to provide early warnings of increased activity during these visits.

Investigators in Israel perform the largest retrospective review of patients with rheumatic fever in a developed country, spanning 25 years of research.

Potent and moderate topical corticosteroids were likely to be effective than milder options for patients with moderate or severe eczema.

After more promising long-term data, Apellis announced plans to seek regulatory approval. An investigator explains what value it could bring to patients.

The use and legalization of cannabis products has been increasing in the US for a variety of medical concerns. Investigators aim to better understand the risks and benefits of owning a medical marijuana card.

Similar pediatric postoperative mortality rates were observed in Black patients in the highest socioeconomic category and White patients in the lowest socioeconomic category.

Deep learning analyses of photographic images and other test results in clinical trials may reduce cost and improve the consistency and accuracy of end point assessments.

Investigators proposed limitations to epoxy chemicals in workplace environments, as a substantial number of patients reacted to the epoxy hardener compounds featured in the study.

The results lead investigators to question the usefulness of prehabilitation before total knee replacement to improve functional outcomes in patients with osteoarthritis.

Upadacitinib is now approved for ulcerative colitis, atopic dermatitis, and psoriatic arthritis.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.